Using a FLCN-deficient kidney model, it was found that FLCN loss upregulates PGC1α expression, which results in elevated mitochondrial function and oxidative metabolism in renal cancer cells (Hasumi et al., 2012). The gene discussed is PPARGC1A; the disease is renal carcinoma.